Author:
Kobayashi Takao,Nakabayashi Masao,Yoshioka Akira,Maeda Makoto,Ikenoue Tsuyomu
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Ministry of Health, Labour and Welfare. Vital statistics of Japan: number of maternal deaths and death rates by selected causes (1980, 1985, 1988–2009).
2. Martinowitz U, Michaelson M, Israeli Multidisciplinary rFVIIa Task Force. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost. 2005;3:640–8.
3. Lusher JM. Recombinant factor VIIa (Novoseven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors. Haemostasis. 1996;26:124–30.
4. Lisman T, Adelmeijer J, Cauwenberghs S, van Pampus ECM, Heemkerk JWN, de Groot PG. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost. 2005;3:742–51.
5. Mittal S, Watson HG. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions. Br J Haematol. 2006;133:355–63.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献